A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas

JAMA Dermatol. 2017 Apr 1;153(4):321-322. doi: 10.1001/jamadermatol.2016.5058.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anilides / administration & dosage*
  • Carcinoma, Basal Cell / diagnosis
  • Carcinoma, Basal Cell / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Neoplasm Staging
  • Pyridines / administration & dosage*
  • Skin / pathology
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Anilides
  • HhAntag691
  • Pyridines